BLOOD ADV 润色咨询

Blood Advances

出版年份：暂无数据 年文章数：2258 投稿命中率： 开通期刊会员，数据随心看

出版周期：S 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2201063, encodeId=b8c622010632d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞免疫治疗基础研究<br>经验分享：需要审稿费75$.审稿速度还是非常快，2周回了两个审稿专家意见，给了3个月时间大修。大修回去之后约2周返回意见给小修，小修回去之后立马接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419f5093273, createdName=145d9e7cm85暂无昵称, createdTime=Mon Apr 29 14:03:27 CST 2024, time=2024-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1204916, encodeId=79d6120491694, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:6.77<br>经验分享：2月22日投的sti m ulus report，3月22日三个评审的意见都回来了，编辑建议拒稿。三个评审的意见都很细致，看得出来期刊要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=伊丽莎白打工, createdTime=Tue Mar 22 12:24:03 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799561, encodeId=fd8be9956170, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：血液学;血液病;淋巴肿瘤<br>经验分享：Blood的姊妹刊！潜力巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Jun 24 14:27:10 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914293, encodeId=19c69142931a, content=需要审稿费，好像是75美元，速度挺快的，隔天就被拒了，😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Thu Jan 07 08:12:18 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2024-04-29 145d9e7cm85暂无昵称 来自浙江省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：细胞免疫治疗基础研究
    经验分享：需要审稿费75$.审稿速度还是非常快，2周回了两个审稿专家意见，给了3个月时间大修。大修回去之后约2周返回意见给小修，小修回去之后立马接受了。

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2201063, encodeId=b8c622010632d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞免疫治疗基础研究<br>经验分享：需要审稿费75$.审稿速度还是非常快，2周回了两个审稿专家意见，给了3个月时间大修。大修回去之后约2周返回意见给小修，小修回去之后立马接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419f5093273, createdName=145d9e7cm85暂无昵称, createdTime=Mon Apr 29 14:03:27 CST 2024, time=2024-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1204916, encodeId=79d6120491694, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:6.77<br>经验分享：2月22日投的sti m ulus report，3月22日三个评审的意见都回来了，编辑建议拒稿。三个评审的意见都很细致，看得出来期刊要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=伊丽莎白打工, createdTime=Tue Mar 22 12:24:03 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799561, encodeId=fd8be9956170, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：血液学;血液病;淋巴肿瘤<br>经验分享：Blood的姊妹刊！潜力巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Jun 24 14:27:10 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914293, encodeId=19c69142931a, content=需要审稿费，好像是75美元，速度挺快的，隔天就被拒了，😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Thu Jan 07 08:12:18 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2022-03-22 伊丽莎白打工

    审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:6.77
    经验分享：2月22日投的sti m ulus report，3月22日三个评审的意见都回来了，编辑建议拒稿。三个评审的意见都很细致，看得出来期刊要求很高。

    7

    展开7条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2201063, encodeId=b8c622010632d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞免疫治疗基础研究<br>经验分享：需要审稿费75$.审稿速度还是非常快，2周回了两个审稿专家意见，给了3个月时间大修。大修回去之后约2周返回意见给小修，小修回去之后立马接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419f5093273, createdName=145d9e7cm85暂无昵称, createdTime=Mon Apr 29 14:03:27 CST 2024, time=2024-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1204916, encodeId=79d6120491694, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:6.77<br>经验分享：2月22日投的sti m ulus report，3月22日三个评审的意见都回来了，编辑建议拒稿。三个评审的意见都很细致，看得出来期刊要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=伊丽莎白打工, createdTime=Tue Mar 22 12:24:03 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799561, encodeId=fd8be9956170, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：血液学;血液病;淋巴肿瘤<br>经验分享：Blood的姊妹刊！潜力巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Jun 24 14:27:10 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914293, encodeId=19c69142931a, content=需要审稿费，好像是75美元，速度挺快的，隔天就被拒了，😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Thu Jan 07 08:12:18 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2020-06-24 lovetcm

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向：血液学;血液病;淋巴肿瘤
    经验分享：Blood的姊妹刊！潜力巨大

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2201063, encodeId=b8c622010632d, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞免疫治疗基础研究<br>经验分享：需要审稿费75$.审稿速度还是非常快，2周回了两个审稿专家意见，给了3个月时间大修。大修回去之后约2周返回意见给小修，小修回去之后立马接受了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=419f5093273, createdName=145d9e7cm85暂无昵称, createdTime=Mon Apr 29 14:03:27 CST 2024, time=2024-04-29, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1204916, encodeId=79d6120491694, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:6.77<br>经验分享：2月22日投的sti m ulus report，3月22日三个评审的意见都回来了，编辑建议拒稿。三个评审的意见都很细致，看得出来期刊要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=伊丽莎白打工, createdTime=Tue Mar 22 12:24:03 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799561, encodeId=fd8be9956170, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：血液学;血液病;淋巴肿瘤<br>经验分享：Blood的姊妹刊！潜力巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=490, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Jun 24 14:27:10 CST 2020, time=2020-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914293, encodeId=19c69142931a, content=需要审稿费，好像是75美元，速度挺快的，隔天就被拒了，😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=420, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=两难不难, createdTime=Thu Jan 07 08:12:18 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2021-01-07 两难不难

    需要审稿费，好像是75美元，速度挺快的，隔天就被拒了，😂😂

    0

共16条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分